Supriya Lifescience Ltd
SUPRIYASupriya Lifescience Ltd
SUPRIYAPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
26.51 | 4.56 | 0.15% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.69 | 5.96 | 0.57% |
Forecast & Ratings
Detailed Forecastfrom 2 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Supriya Lifescience is a manufacturer of pharmaceutical preparation.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 140.28 | 172.39 | 190.95 | 221.51 | 285.86 | 322.71 | 396.22 | 537.63 | 470.43 | 564.87 | ||||||||||
Raw Materials | 95.20 | 120.02 | 112.46 | 127.94 | 146.07 | 152.38 | 140.57 | 198.83 | 187.32 | 381.94 | ||||||||||
Power & Fuel Cost | 5.25 | 6.64 | 6.93 | 7.03 | 0.00 | 8.97 | 9.24 | 14.07 | 20.95 | |||||||||||
Employee Cost | 9.29 | 13.47 | 15.49 | 16.30 | 0.00 | 18.88 | 32.76 | 49.08 | 55.58 | |||||||||||
Selling & Administrative Expenses | 7.50 | 9.53 | 8.11 | 15.85 | 0.00 | 30.10 | 31.88 | 33.83 | 38.56 | |||||||||||
Operating & Other expenses | 3.47 | 0.67 | 23.39 | 23.84 | 67.03 | 2.92 | 3.62 | 20.25 | 29.63 | |||||||||||
EBITDA | 19.57 | 22.06 | 24.57 | 30.55 | 72.76 | 109.46 | 178.15 | 221.57 | 138.39 | 182.93 | ||||||||||
Depreciation/Amortization | 2.49 | 3.95 | 4.75 | 5.33 | 5.44 | 6.41 | 6.76 | 10.12 | 11.82 | 14.91 | ||||||||||
PBIT | 17.08 | 18.11 | 19.82 | 25.22 | 67.32 | 103.05 | 171.39 | 211.45 | 126.57 | 168.02 | ||||||||||
Interest & Other Items | 6.92 | 10.04 | 11.76 | 10.75 | 10.22 | 6.85 | 4.08 | 4.20 | 3.08 | 2.22 | ||||||||||
PBT | 10.16 | 8.07 | 8.06 | 14.47 | 57.10 | 96.20 | 167.31 | 207.25 | 123.49 | 165.80 | ||||||||||
Taxes & Other Items | 1.95 | 2.36 | 2.40 | 5.74 | 17.68 | 22.84 | 43.71 | 55.44 | 33.63 | 45.40 | ||||||||||
Net Income | 8.21 | 5.71 | 5.66 | 8.73 | 39.42 | 73.36 | 123.60 | 151.81 | 89.86 | 120.40 | ||||||||||
EPS | 3.37 | 1.17 | 0.77 | 1.19 | 5.39 | 10.02 | 16.89 | 19.76 | 11.17 | 14.96 | ||||||||||
DPS | 0.24 | 0.20 | 0.00 | 0.00 | 0.00 | 2.00 | 0.54 | 0.60 | 0.60 | 0.60 | ||||||||||
Payout ratio | 0.07 | 0.17 | 0.00 | 0.00 | 0.00 | 0.20 | 0.03 | 0.03 | 0.05 | 0.04 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Supriya Lifescience Ltd | 35.53 | 4.56 | 0.15% |
Sun Pharmaceutical Industries Ltd | 42.53 | 6.08 | 0.77% |
Cipla Ltd | 40.34 | 4.77 | 0.61% |
Dr Reddy's Laboratories Ltd | 22.92 | 4.44 | 0.64% |
Price Comparison
Compare SUPRIYA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 2 Mutual Funds holding Supriya Lifescience Ltd
Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Motilal Oswal Nifty Microcap 250 Index Fund- Direct- Growth Option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0406% | Percentage of the fund’s portfolio invested in the stock 0.16% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 202/326 (+14) |
Groww Nifty Total Market Index Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0002% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 726/811 (+14) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 15, 2023
Dividend/Share
₹0.60
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 1, 2022
Dividend/Share
₹0.60
Ex DateEx Date
Sep 1, 2022
News & Opinions
Supriya Lifescience Aims To Double Revenue To Rs 1,000 Crore By FY27 — Know Your Company
2 months ago•Bloomberg Quint
Supriya Lifescience Q3 Review - Strong Growth Across Board On Favorable Geographical, Product Mix: DRChoksey
2 months ago•Bloomberg Quint
Supriya Lifescience shares rise post tie-up with US-based Plasma Nutrition
9 months ago•The Hindu Businessline
Supriya Lifescience ties up with US-based Plasma Nutrition, stock surges 7%
9 months ago•Business Today
Buy Supriya Lifescience; target of Rs 278: KR Choksey
1 year ago•Moneycontrol
Supriya Lifescience - Muted Performance On Account Of Multiple Macro Headwinds: KRChoksey
1 year ago•Bloomberg Quint
EKI Energy Services Ltd leads gainers in ‘A’ group
1 year ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 16.26%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 0.11% to 0.14%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 59.41%, vs industry avg of 9.82%